Banner Image

Test Directory

B-Cell Receptor IGK Gene Rearrangement, PCR

Order Code: BCRIGK

Test Summary

This assay, which interrogates the immunoglobulin kappa light chain gene (IGK) by a PCR method based on the BIOMED-2 consensus, is useful for establishing clonality of B-cell lymphoid neoplasms and in the identification of minimal residual disease or early recurrence in patients with a previous diagnosis of B-cell neoplasm. It can be used in association with the immunoglobulin heavy chain (IGH PCR assay test code 90362), since false-negative results can occur in up to 10-25% of B-cell malignancies with testing IGK only.

Aliases

  • N/A

Specimen Collection

Order Code

BCRIGK

EPIC (Premier) Code

LAB5393

Includes

Test includes pathologist interpretation

CPT Code

  • 81264
  • 84999 (HCPCS: G0452)

Billing Code

  • 670579
  • 670580

CPT Statement

Methodology

Polymerase Chain Reaction (PCR) • Fragment Analysis

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675

Department

Reference Testing

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Daily; Report available: 5 days

Specimen Collection

Billing

CPT Code

  • 81264
  • 84999 (HCPCS: G0452)

Billing Code

  • 670579
  • 670580

CPT Statement

Result Information

Methodology

Polymerase Chain Reaction (PCR) • Fragment Analysis

Testing Laboratory

N/A

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Daily; Report available: 5 days